Home › NDC Lookup › RxCUI directory › RxCUI 1363288

12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet — RxCUI 1363288

RxNorm drug concept · Semantic clinical drug
RxCUI 1363288 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1363288
Official name12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chlorpheniramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an antihistamine used to temporarily relieve classic hay fever and allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy throat. It works o...
  • What is chlorpheniramine actually used for?
  • Yes — drowsiness is one of the most common effects of chlorpheniramine, and it can be significant. Don't plan on driving or operating heavy machinery until you know how your body r...
  • It's best to skip the alcohol while you're taking chlorpheniramine. Alcohol makes the drowsiness much stronger, which can be unsafe — especially if you need to drive or stay alert....
📖 Read our full Chlorpheniramine guide →

🕸️ Concept Web — How 12 HR chlorpheniramine maleate 12 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet RxCUI 1363288

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Chlorpheniramine 2400
    • Chlorpheniramine maleate 142429
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Chlor-Trimeton 202384
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlorpheniramine Extended Release Oral Tablet 371448
    • Chlorpheniramine maleate Extended Release Oral Tablet 2646584
    • Chlorpheniramine Oral Product 1155456
    • Chlorpheniramine Pill 1155457
    • Chlorpheniramine maleate Oral Product 2661590
    • Chlorpheniramine maleate Pill 2659406
    • Chlorpheniramine Extended Release Oral Tablet [Chlor-Trimeton] 892082
    • Chlorpheniramine maleate Extended Release Oral Tablet [Chlor-Trimeton] 2658090
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chlorpheniramine maleate 12 MG 1190896
    • 12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] 1363290
    • Chlorpheniramine maleate 12 MG [Chlor-Trimeton] 1363289

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlorpheniramine maleate 12 MG SCDC · 1190896
  • Chlorpheniramine Extended Release Oral Tablet SCDF · 371448
  • Chlorpheniramine maleate Extended Release Oral Tablet SCDFP · 2646584
  • Chlorpheniramine Oral Product SCDG · 1155456
  • Chlorpheniramine Pill SCDG · 1155457
  • Chlorpheniramine maleate Oral Product SCDGP · 2661590
  • Chlorpheniramine maleate Pill SCDGP · 2659406

Brand-Name Concepts

  • 12 HR chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] SBD · 1363290
  • Chlorpheniramine maleate 12 MG [Chlor-Trimeton] SBDC · 1363289
  • Chlorpheniramine Extended Release Oral Tablet [Chlor-Trimeton] SBDF · 892082
  • Chlorpheniramine maleate Extended Release Oral Tablet [Chlor-Trimeton] SBDFP · 2658090
  • Chlor-Trimeton Oral Product SBDG · 1169454
  • Chlor-Trimeton Pill SBDG · 1169455
  • Chlor-Trimeton BN · 202384

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 1363288 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10702-0017-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10702... Chlorphen-12 KVK-Tech, Inc. 2010-06-15
10702-0017-06 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10702-... Chlorphen-12 KVK-Tech, Inc. 2010-06-15
10702-0017-24 24 TABLET, FILM COATED, EXTENDED RELEASE in 1 CARTON (10702-... Chlorphen-12 KVK-Tech, Inc. 2010-06-15
10702-0017-54 50 PACKAGE in 1 CARTON (10702-017-54) / 4 TABLET, FILM COAT... Chlorphen-12 KVK-Tech, Inc. 2018-11-29
69842-0017-24 24 TABLET, FILM COATED, EXTENDED RELEASE in 1 CARTON (69842-... Allergy Relief CVS Pharmacy 2011-01-06
Observed labelers: KVK-Tech, Inc. (4) · CVS Pharmacy (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.